Immucell Corp.
ICCC
Get informed when a big investor buys or sells
+ FollowMarket Cap$88.66M
Close$
$6.58
37.7% downside
Current Fair Value
37.7% downsideOvervalued by 37.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $88.66 Million |
|---|---|
| Enterprise Value | $85.45 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | 0.57 |
| Outstanding Shares | 9,064,785 |
Return
| Return on Equity | 2.51% |
|---|---|
| Return on Assets | 1.69% |
| Return on Invested Capital | 9.29% |
Valuation & Multiples
| P/E Ratio | 115.84 |
|---|---|
| PEG | 43.62 |
| Price to Sales | 3.52 |
| Price to Book Ratio | 3.52 |
| Enterprise Value to Revenue | 2.79 |
| Enterprise Value to EBIT | 21.8 |
| Enterprise Value to Net Income | 108 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$3.26 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$5.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.71%▼ 0.43% |
|---|---|
| Total Invested | $13.40M▲ 54.60% |
| Investors Holding | 31▲ 4.00% |
ESG Score
No data
About Immucell Corp.
CEO: Michael Brigham